¿Qué haremos cuando una IA gane sola el premio Nobel? Reflexiones sobre el Nobel de Química de 2024

Manuel Jesús López Baroni

Resumen


El Premio Nobel de Química de 2024 se ha concedido a John Jumper y a Demis Hassabis por crear el programa que per-mite predecir la estructura tridimensional de las proteínas a partir de la secuencia de los aminoácidos, y a David Baker por el diseño de proteínas ex novo. El galardón reconoce el valor de la interdisciplinariedad y el ingenio humano para afrontar problemas hasta ese momento prácticamente irresolubles, así como las potenciales aplicaciones prácticas si se lograra do-minar completamente este campo del conocimiento. Examinado desde otra perspectiva, el premio nos interroga sobre la naturaleza, función y coexistencia de la Inteligencia Artificial con la actividad científica, así como sobre el creciente poder de las multinacionales a la hora de concentrar los datos y algoritmos que posibilitan la investigación

Recibido: 28/03/2025
Aceptado: 14/04/2025


Palabras clave


Premio nobel; química; proteínas; bioética; inteligencia artificial

Texto completo:

PDF

Referencias


R Jacobsen. Proteínas artificiales. Investigación y Ciencia, 590, 58-67 (2021).

V Marx. Method of the Year: protein structure prediction. Nat. Methods, 19, 5–10 (2022).

S Reardon. Five protein-design questions that still challenge AI. Nature, 635(8037), 246-248 (2024).

A Ourmazd, K Moffat, EE Lattman. Structural biology is solved −now what?” Nat. Methods, 19, 24–26 (2022).

E Callaway. What's next for the AI protein-folding revolution. Nature, 604(7905), 234-238 (2022)

E Callaway. AI tools are designing entirely new proteins that could transform medicine. Nature, 619(7969), 236-238 (2023).

RA Chica, N Ferruz. What does it take for an ‘AlphaFold Mo-ment’ in functional protein engineering and design? Nat. Bio-technol., 42, 173–174 (2024).

S Paiva. Protein prediction takes the prize. Nat. Chem., 16(12), 1938 (2024).

F Graham. Daily briefing: AlphaFold developers share Nobel Prize in Chemistry. Nature, Oct 9, (2024). doi: 10.1038/d41586-024-03325-1

Editorial. AI pioneers win 2024 Nobel prizes. Nature Machine Intelligence, 6, 1271 (2024)

D Baker. NobelPrize: https://www.nobelprize.org/prizes/ chem-istry/2024/baker/interview. Última visita, marzo de 2025.

NobelPrize. https://www.nobelprize.org/prizes/chemistry/2024/ jumper/interview/ Última visita, marzo de 2025.

J Jumper y D Hassabis. Protein structure predictions to atomic accuracy with AlphaFold. Nat. Methods, 19, 11–12 (2022).

LA Abriata. The Nobel Prize in Chemistry: past, present, and future of AI in biology. Commun. Biol., 7, 1409 (2024).

Editorial. Happy anniversary, PDB!. Nat. Struct. Mol. Biol., 28, 399 (2021).

Editorial. Method of the Year 2021: Protein structure prediction. Nat. Methods, 19, 1 (2022).

E Callaway. AI has dreamt up a blizzard of new proteins. Do any of them actually work? Nature, 634(8034), 532-533 (2024).

E Callaway. Major AlphaFold upgrade offers boost for drug Discovery. Nature, 629(8012), 509-510 (2024).

M Baek, D Baker. Deep learning and protein structure modeling. Nat. Methods, 19, 13–14 (2002).

A Doerr. Protein design: the experts speak. Nat. Biotechnol., 42, 175–178 (2024).

J Jumper. PrizeNobel.org: https://www.nobelprize.org/prizes/ chemistry/2024/jumper/interview/ Última visita: marzo de 2025.

E Nji, AFA Moumbock, KC Cramer, NV Rüffin, J Davis, OA Asojo et al. Supporting structural biologists in Africa requires re-sources and capacity building. Nat. Struct. Mol. Biol., 31, 1814–1815 (2024)

E Nji, KC Cramer, NV Rüffin, FG Fofana, W Heiba, S Sankhe. Leveraging AlphaFold for innovation and sustainable health re-search in Africa. Nat. Commun., 16, 1334 (2025).

E Callaway. Developers of AlphaFold win Chemistry Nobel. Nature, 634, 525-526 (2024).

J Apfeld. Keeping in touch with the road not taken. Nat. Struct. Mol. Biol., 31, 1816–1817 (2024).

P Ball. If the Nobel Prizes were designed today, what would change? Nature, 634(8035), 763-764 (2024).

TJ O`Brien y N Cassidy. Assessing the Risks Posed by the Con-vergence of Artificial Intelligence and Biotechnology. Health Security, 18(3), 219-227 (2020).

F Urbina, F Lentzos, C Invemizzi, S Ekins. Dual use of artificial-intelligence-powered drug discovery. Nat. Mach. Intell., 4(3), 189–191 (2022).

G. Church. Regenesis, How Synthetic Biology Will Reinvent Nature and Ourselves. Regis University, Denver, CO, USA (2011).

J Sampedro. La vida a través del espejo. Diario El País, España. 14 de diciembre (2024).

P Katarzyna, D Agashe, Y Belkaid, DM Bittencourt, Y Cai, MW Chang, et al. Confronting risks of mirror life. Science, 386, 1351-1353 (2024).

M Kozlov. US funders to tighten oversight of controversial 'gain of function' research. Nature, 629 (8012), 510-511 (2024).

D Castelvecchi, E Callaway, D Kwon. AI comes to the Nobels: double win sparks debate about scientific fields. Nature, Oct. 10 (2024). doi: 10.1038/d41586-024-03310-8

Editorial. 30 years of structural and molecular biology and count-ing. Nat. Struct. Mol. Biol., 31, 1811 (2024).

E Gibney. John Hopfield has had a varied career and delights in working in the cracks between disciplines. Nature, 635(8037), 16-17 (2024).

E Gibney y D Castelvecchi. Physics Nobel scooped by machine-learning pioneers. Nature, 634(8034), 523-524 (2024).

European Group on Ethics in Science and New Technologies. Statement on artificial intelligence, robotics and 'autonomous' systems: Brussels, 9 March (2018).

S Gibson y J Newman. What Happens When AI invents: Is the Invention Patentable? AI Magazine, 41(4), 96-99 (2020).

T Cech. El Catalizador. Editorial Ariel (2025). ISBN: 978-84-344-3845-3




Depósito Legal: PPI200602ME2232
ISSN: 1856-5301

DOI: https://doi.org/10.53766/AVANQUIM

Creative Commons License
Todos los documentos publicados en esta revista se distribuyen bajo una
Licencia Creative Commons Atribución -No Comercial- Compartir Igual 4.0 Internacional.
Por lo que el envío, procesamiento y publicación de artículos en la revista es totalmente gratuito.